Baird lowered the firm’s price target on Revvity (RVTY) to $127 from $141 and keeps an Outperform rating on the shares. The firm upated its model ahead of its Q1 results.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
- Revvity price target lowered to $120 from $140 at Bernstein
- Revvity price target lowered to $116 from $143 at BofA
- Revvity price target lowered to $110 from $140 at Barclays
- Revvity announces FDA approval for Auto-Pure 2400 liquid handling platform
- Revvity enters agreement with Genomics England for Generation Study collab
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue